Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies
Sign Up to like & getrecommendations! Published in 2020 at "Pathogens"
DOI: 10.3390/pathogens9121067
Abstract: The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally. Although several rapid commercial serological assays have been developed, little is known about their performance… read more here.
Keywords: available rapid; serological assays; performance; sars cov ... See more keywords